HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Outcome of patients with human immunodeficiency virus on maintenance hemodialysis.

Abstract
Fifty-one adults with HIV infection, including 20 chronic hemodialysis patients with superimposed HIV infection and 31 patients with HIV-associated nephropathy requiring chronic maintenance hemodialysis were followed to evaluate survival on outpatient dialysis in relation to the clinical stage of the HIV infection. Regardless of when they contracted the infection, AIDS patients who required maintenance hemodialysis had a poor prognosis. All 17 patients who developed AIDS died after a mean of 93 +/- 32 days on hemodialysis (median 30 days; range 2 to 540 days). On the other hand, 12 asymptomatic HIV carriers were alive after a mean follow-up on chronic hemodialysis of 488 +/- 75 days (median 420 days; range 142 to 850 days); and five hemodialyzed patients with ARC were alive after 564 +/- 191 days (median 420 days; range 150 to 1230 days). The data confirm the lack of effectiveness of maintenance hemodialysis for prolonging life in patients with AIDS. This dismal prognosis was evident whether renal failure antedated HIV infection or whether it was HIV-associated. In asymptomatic HIV carriers and in patients with ARC, however, maintenance hemodialysis provides meaningful, long-term life support.
AuthorsC Ortiz, R Meneses, D Jaffe, J A Fernandez, G Perez, J J Bourgoignie
JournalKidney international (Kidney Int) Vol. 34 Issue 2 Pg. 248-53 (Aug 1988) ISSN: 0085-2538 [Print] United States
PMID3184600 (Publication Type: Journal Article)
Topics
  • AIDS-Related Complex (mortality)
  • Acquired Immunodeficiency Syndrome (mortality)
  • Adult
  • Aged
  • Ambulatory Care
  • Female
  • HIV Seropositivity (mortality)
  • Humans
  • Male
  • Middle Aged
  • Prognosis
  • Renal Dialysis
  • Retrospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: